Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Study of CD19/CD22 Tan CAR T Cells in Relapsed and/or Chemotherapy Refractory B-cell Leukemias and Lymphomas

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03185494
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:19.465653+00:00
Published At
2019-04-17T00:00:00+00:00
Record Updated At
2019-04-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hematopoietic/Lymphoid Cancer", "Adult Acute Lymphoblastic Leukemia in Remission", "B-cell Adult Acute Lymphoblastic Leukemia", "B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)", "Prolymphocytic Leukemia", "Recurrent Adult Diffuse Large Cell Lymphoma", "Recurrent Grade 1 Follicular Lymphoma", "Recurrent Grade 2 Follicular Lymphoma", "Recurrent Grade 3 Follicular Lymphoma", "Recurrent Mantle Cell Lymphoma", "Refractory Chronic Lymphocytic Leukemia", "Stage III Adult Diffuse Large Cell Lymphoma", "Stage III Chronic Lymphocytic Leukemia", "Stage III Grade 1 Follicular Lymphoma", "Stage III Grade 2 Follicular Lymphoma", "Stage III Grade 3 Follicular Lymphoma", "Stage III Mantle Cell Lymphoma", "Stage IV Adult Diffuse Large Cell Lymphoma", "Stage IV Chronic Lymphocytic Leukemia", "Stage IV Grade 1 Follicular Lymphoma", "Stage IV Grade 2 Follicular Lymphoma", "Stage IV Grade 3 Follicular Lymphoma", "Stage IV Mantle Cell Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-04-17"
protocolSection.identificationModule.nctId
"NCT03185494"
protocolSection.identificationModule.officialTitle
"Clinical Study of CD19/CD22 Tan CAR T Cells in Relapsed and/or Chemotherapy Refractory B-cell Leukemias and Lymphomas"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Hematopoietic/Lymphoid Cancer (protocolSection.conditionsModule.conditions)
  • Adult Acute Lymphoblastic Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • B-cell Adult Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis) (protocolSection.conditionsModule.conditions)
  • Prolymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage III Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage III Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage IV Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.